Journal of International Obstetrics and Gynecology ›› 2023, Vol. 50 ›› Issue (5): 550-554.doi: 10.12280/gjfckx.20230228
Previous Articles Next Articles
LIU Jun-jun, ZHANG Ling, LIU Yi()
Received:
2023-03-24
Published:
2023-10-15
Online:
2023-10-16
Contact:
LIU Yi, E-mail: LIU Jun-jun, ZHANG Ling, LIU Yi. Research Progress of Glucose Metabolic Reprogramming in Endometriosis[J]. Journal of International Obstetrics and Gynecology, 2023, 50(5): 550-554.
Add to citation manager EndNote|Ris|BibTeX
[1] |
Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate[J]. Cancer Cell, 2012, 21(3):297-308. doi: 10.1016/j.ccr.2012.02.014.
pmid: 22439925 |
[2] |
Young VJ, Brown JK, Maybin J, et al. Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis[J]. J Clin Endocrinol Metab, 2014, 99(9):3450-3459. doi: 10.1210/jc.2014-1026.
pmid: 24796928 |
[3] | Kobayashi H, Imanaka S. Understanding the molecular mechanisms of macrophage polarization and metabolic reprogramming in endometriosis: A narrative review[J]. Reprod Med Biol, 2022, 21(1):e12488. doi: 10.1002/rmb2.12488. |
[4] | Bonavina G, Taylor HS. Endometriosis-associated infertility: From pathophysiology to tailored treatment[J]. Front Endocrinol(Lausanne), 2022, 13:1020827. doi: 10.3389/fendo.2022.1020827. |
[5] | Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression[J]. Science, 2020, 368(6487):eaaw5473. doi: 10.1126/science.aaw5473. |
[6] |
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation[J]. Science, 2009, 324(5930):1029-1033. doi: 10.1126/science.1160809.
pmid: 19460998 |
[7] |
Xia L, Oyang L, Lin J, et al. The cancer metabolic reprogramming and immune response[J]. Mol Cancer, 2021, 20(1):28. doi: 10.1186/s12943-021-01316-8.
pmid: 33546704 |
[8] | Baik SH, Kang S, Lee W, et al. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer′s Disease[J]. Cell Metab, 2019, 30(3):493-507.e6. doi: 10.1016/j.cmet.2019.06.005. |
[9] | Srivastava RK, Sapra L, Mishra PK. Osteometabolism: Metabolic Alterations in Bone Pathologies[J]. Cells, 2022, 11(23):3943. doi: 10.3390/cells11233943. |
[10] | Wei X, Hou Y, Long M, et al. Advances in energy metabolism in renal fibrosis[J]. Life Sci, 2023, 312:121033. doi: 10.1016/j.lfs.2022.121033. |
[11] | Shen L, Chen W, Ding J, et al. The role of metabolic reprogramming of oxygen-induced macrophages in the dynamic changes of atherosclerotic plaques[J]. FASEB J, 2023, 37(3):e22791. doi: 10.1096/fj.202201486R. |
[12] | Zhang HP, Sun YL, Wang YF, et al. Recent developments in the immunopathology of COVID-19[J]. Allergy, 2023, 78(2):369-388. doi: 10.1111/all.15593. |
[13] |
Qi X, Zhang Y, Ji H, et al. Knockdown of prohibitin expression promotes glucose metabolism in eutopic endometrial stromal cells from women with endometriosis[J]. Reprod Biomed Online, 2014, 29(6):761-770. doi: 10.1016/j.rbmo.2014.09.004.
pmid: 25444511 |
[14] |
McKinnon B, Bertschi D, Wotzkow C, et al. Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions[J]. J Mol Endocrinol, 2014, 52(2):169-179. doi: 10.1530/JME-13-0194.
pmid: 24412827 |
[15] | Bahrami A, Ayen E, Razi M, et al. Effects of atorvastatin and resveratrol against the experimental endometriosis; evidence for glucose and monocarboxylate transporters, neoangiogenesis[J]. Life Sci, 2021, 272:119230. doi: 10.1016/j.lfs.2021.119230. |
[16] | Zhou J, Ding ZM, Hardiman PJ. Understanding the Role of Gui-Zhi-Fu-Ling-Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics[J]. Evid Based Complement Alternat Med, 2018, 2018:9864963. doi: 10.1155/2018/9864963. |
[17] | Zheng J, Dai Y, Lin X, et al. Hypoxia-induced lactate dehydrogenase A protects cells from apoptosis in endometriosis[J]. Mol Med Rep, 2021, 24(3):637. doi: 10.3892/mmr.2021.12276. |
[18] |
Sharma D, Singh M, Rani R. Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics[J]. Semin Cancer Biol, 2022, 87:184-195. doi: 10.1016/j.semcancer.2022.11.007.
pmid: 36371026 |
[19] | Lee HC, Lin SC, Wu MH, et al. Induction of Pyruvate Dehydrogenase Kinase 1 by Hypoxia Alters Cellular Metabolism and Inhibits Apoptosis in Endometriotic Stromal Cells[J]. Reprod Sci, 2019, 26(6):734-744. doi: 10.1177/1933719118789513. |
[20] | Horne AW, Ahmad SF, Carter R, et al. Repurposing dichloroacetate for the treatment of women with endometriosis[J]. Proc Natl Acad Sci U S A, 2019, 116(51):25389-25391. doi: 10.1073/pnas.1916144116. |
[21] |
Kobayashi H, Kimura M, Maruyama S, et al. Revisiting estrogen-dependent signaling pathways in endometriosis: Potential targets for non-hormonal therapeutics[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 258:103-110. doi: 10.1016/j.ejogrb.2020.12.044.
pmid: 33421806 |
[22] | Atkins HM, Bharadwaj MS, O′Brien Cox A, et al. Endometrium and endometriosis tissue mitochondrial energy metabolism in a nonhuman primate model[J]. Reprod Biol Endocrinol, 2019, 17(1):70. doi: 10.1186/s12958-019-0513-8. |
[23] | Yao Q, Jing G, Zhang X, et al. Cinnamic acid inhibits cell viability, invasion, and glycolysis in primary endometrial stromal cells by suppressing NF-κB-induced transcription of PKM2[J]. Biosci Rep,2021 Sep 9;BSR20211828. doi: 10.1042/BSR20211828. |
[24] | Hou S, Lei S, Peng H, et al. Downregulating HK2 inhibits proliferation of endometrial stromal cells through a noncanonical pathway involving phosphorylation of signal transducer and activator of transcription 1 in endometriosis[J]. Biol Reprod, 2022, 107(2):488-499. doi: 10.1093/biolre/ioac081. |
[25] | Wang Y, Xiu J, Yang T, et al. HSF1 promotes endometriosis development and glycolysis by up-regulating PFKFB3 expression[J]. Reprod Biol Endocrinol, 2021, 19(1):86. doi: 10.1186/s12958-021-00770-9. |
[26] |
Lu C, Qiao P, Fu R, et al. Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis[J]. Cell Death Dis, 2022, 13(9):790. doi: 10.1038/s41419-022-05241-6.
pmid: 36109523 |
[27] |
Laganà AS, Salmeri FM, Ban Frangež H, et al. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease[J]. Gynecol Endocrinol, 2020, 36(5):441-444. doi: 10.1080/09513590.2019.1683821.
pmid: 31663401 |
[28] | Gou Y, Li X, Li P, et al. Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis[J]. Hum Reprod, 2019, 34(4):646-658. doi: 10.1093/humrep/dez019. |
[29] |
Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis[J]. Hum Reprod Update, 2019, 25(5):564-591. doi: 10.1093/humupd/dmz018.
pmid: 31424502 |
[30] |
Johan MZ, Ingman WV, Robertson SA, et al. Macrophages infiltrating endometriosis-like lesions exhibit progressive phenotype changes in a heterologous mouse model[J]. J Reprod Immunol, 2019, 132:1-8. doi: 10.1016/j.jri.2019.01.002.
pmid: 30772629 |
[31] | Gou Y, Wang H, Wang T, et al. Ectopic endometriotic stromal cells-derived lactate induces M2 macrophage polarization via Mettl3/Trib1/ERK/STAT3 signalling pathway in endometriosis[J]. Immunology, 2023, 168(3):389-402. doi: 10.1111/imm.13574. |
[32] | Mao J, Zhang J, Cai L, et al. Elevated prohibitin 1 expression mitigates glucose metabolism defects in granulosa cells of infertile patients with endometriosis[J]. Mol Hum Reprod, 2022, 28(6):gaac018. doi: 10.1093/molehr/gaac018. |
[33] |
Pocate-Cheriet K, Santulli P, Kateb F, et al. The follicular fluid metabolome differs according to the endometriosis phenotype[J]. Reprod Biomed Online, 2020, 41(6):1023-1037. doi: 10.1016/j.rbmo.2020.09.002.
pmid: 33046374 |
[34] | Ma LN, Huang XB, Muyayalo KP, et al. Lactic Acid: A Novel Signaling Molecule in Early Pregnancy?[J]. Front Immunol, 2020, 11:279. doi: 10.3389/fimmu.2020.00279. |
[35] |
Su Y, Guo S, Liu C, et al. Endometrial pyruvate kinase M2 is essential for decidualization during early pregnancy[J]. J Endocrinol, 2020, 245(3):357-368. doi: 10.1530/JOE-19-0553.
pmid: 32208360 |
[1] | CAO Xiu-rong, ZHOU Wen-bai, FAN Xiang, WANG Yi-fei, ZHU Peng-feng. Single-Cell RNA Sequencing Analysis of the Angiogenesis Mechanism in Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 199-205. |
[2] | YIN Ting, CONG Hui-fang. Progress in Immunological of Endometriosis and Pain Sensitization [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 206-210. |
[3] | JIANG Ai-mei, ZHANG Xin-mei. Advances in the Treatment of Abdominal Wall Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 211-216. |
[4] | ZHANG Yun-feng, ZHANG Wan-yue, LU Yue, WANG Yang-yang, JING Jia-yu, MU Jing-yi, WANG Yue. Research Progress of ARID1A and PIK3CA Mutations in Malignant Transformation of Ovarian Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 19-22. |
[5] | SHI Bai-chao, WANG Yu, CHANG Hui, LU Feng-juan, GUAN Mu-xin, YU Jian-nan, WU Xiao-ke. Mechanism of Traditional Chinese Medicine and Natural Products in Improving Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 66-71. |
[6] | GUO Xi, LIU Si-min, WEI Jia, YANG Yong-xiu. Malignant Transformation of Ovarian and Tube Endometriosis into Clear Cell Carcinoma: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 680-683. |
[7] | ZHANG Yan, ZHANG Yi-ming. A Case of Pelvic Abscess Following Oocyte Retrieval in A Patient with Adenomyosis and Ovarian Endometriosis Cyst [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 717-720. |
[8] | LI Hui-min, HU Ya-li, ZHANG Sen-huai, MA Xiao-mei, XU Fei-xue. Progress in the Application of High Intensity Focused Ultrasound Technology in Obstetric and Gynecological Diseases [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 486-491. |
[9] | GUO Xi, WEI Jia, YANG Yong-xiu. Hormonal Pathways and Regulatory Factors That Lead to Endometrial Disease [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 395-400. |
[10] | SUN Jia-fan, XU Wei, ZHU Shu, WANG Xiu-li. Effect of Dienogest on the Volume of Endometriosis Lesions [J]. Journal of International Obstetrics and Gynecology, 2024, 51(3): 284-289. |
[11] | XU Qian, DUAN Hua, WANG Sha, AN Yuan-yuan. Clinical Analysis of 84 Cases of Cervical Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2024, 51(3): 302-305. |
[12] | YU Liang, YUAN Lin, MENG Huang-yang, YANG Yu-qin, ZHAO Ming-rui, ZHANG Lin, CHENG Wen-jun. The Prognosis Factors Abdominal Wall Endometriosis Associated Clear Cell Carcinoma: A Pooled Analysis Based on Case Reports [J]. Journal of International Obstetrics and Gynecology, 2024, 51(2): 220-227. |
[13] | ZHANG Wei-yue, YANG Jing, JI Jia-nan, LUO Cheng-yan. Research Progress on the Diagnosis and Treatment of Abdominal Wall Endometriosis-Associated Clear Cell Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2024, 51(1): 60-65. |
[14] | XU Ze-mei-hong, YANG Ru-yu, WU Qiong, LYU Yi, LIANG Yan-chun. The Potential Application of Spatial Transcriptome Technology in the Research of Immune Microenvironment of Endometriosi [J]. Journal of International Obstetrics and Gynecology, 2024, 51(1): 82-86. |
[15] | LI Zhen-ying, SUN Xiao-tong, XING Guang-yang, LI Jing-jing, LIU Ting-ting, ZHANG Yi-fan. Research Progress on Sphingolipid Metabolism and Benign and Malignant Gynecological Diseases [J]. Journal of International Obstetrics and Gynecology, 2023, 50(6): 649-654. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||